Test Vaccines Produce Year-Long Immune Response in Most Study ParticipantsResults from PREVAIL I—a large Ebola vaccine study that enrolled more than a thousand Liberians at Redemption Hospital in Monrovia during the first few months of 2015— have been published in the October 12th issue of The New England Journal of Medicine. The study was the first to be conducted by the Partnership for Research on Ebola Virus in Liberia, or PREVAIL. From February 2 through April 30, 2015, PREVAIL enrolled 1,500 men and women ages 18 and older in the study. One group received one test vaccine, the second group the other test vaccine, and the third group received a placebo (saltwater injection). Some participants who received the test vaccines had temporary mild to moderate side effects, including headaches, muscle pain, fever and fatigue.

Source: Daily Observer October 12, 2017 02:26 UTC